SU932985A3 - Способ получени оптически активных или рацемических W-нор-ароматических-13,14-дегидропростагландинов или их солей - Google Patents

Способ получени оптически активных или рацемических W-нор-ароматических-13,14-дегидропростагландинов или их солей Download PDF

Info

Publication number
SU932985A3
SU932985A3 SU772481552A SU2481552A SU932985A3 SU 932985 A3 SU932985 A3 SU 932985A3 SU 772481552 A SU772481552 A SU 772481552A SU 2481552 A SU2481552 A SU 2481552A SU 932985 A3 SU932985 A3 SU 932985A3
Authority
SU
USSR - Soviet Union
Prior art keywords
acid
oxo
trinor
trans
phenylprost
Prior art date
Application number
SU772481552A
Other languages
English (en)
Russian (ru)
Inventor
Гадольфи Кармело
Фаустини Франко
Моретти Уолтер
Маддалена Усарди Мариа
Цезерани Роберто
Original Assignee
Фармиталия Карло Эрба С.П.А. (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2382676A external-priority patent/IT1060884B/it
Priority claimed from IT3045876A external-priority patent/IT1065450B/it
Application filed by Фармиталия Карло Эрба С.П.А. (Фирма) filed Critical Фармиталия Карло Эрба С.П.А. (Фирма)
Application granted granted Critical
Publication of SU932985A3 publication Critical patent/SU932985A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
SU772481552A 1976-06-01 1977-05-25 Способ получени оптически активных или рацемических W-нор-ароматических-13,14-дегидропростагландинов или их солей SU932985A3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2382676A IT1060884B (it) 1976-06-01 1976-06-01 Aromatiche prostaglandine
IT3045876A IT1065450B (it) 1976-12-16 1976-12-16 Oxaprostaglandine

Publications (1)

Publication Number Publication Date
SU932985A3 true SU932985A3 (ru) 1982-05-30

Family

ID=26328426

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772481552A SU932985A3 (ru) 1976-06-01 1977-05-25 Способ получени оптически активных или рацемических W-нор-ароматических-13,14-дегидропростагландинов или их солей

Country Status (18)

Country Link
US (1) US4195183A (OSRAM)
JP (1) JPS52148044A (OSRAM)
AT (2) AT356302B (OSRAM)
AU (1) AU509127B2 (OSRAM)
BE (1) BE855236A (OSRAM)
CA (1) CA1115700A (OSRAM)
CH (1) CH634831A5 (OSRAM)
CS (1) CS192484B2 (OSRAM)
DE (1) DE2721534A1 (OSRAM)
DK (1) DK233377A (OSRAM)
FR (1) FR2368473A1 (OSRAM)
GB (1) GB1583263A (OSRAM)
HU (1) HU181424B (OSRAM)
IL (1) IL51877A (OSRAM)
NL (1) NL7705701A (OSRAM)
NZ (1) NZ184187A (OSRAM)
SE (1) SE436026B (OSRAM)
SU (1) SU932985A3 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
HUE025127T2 (en) * 2002-03-01 2016-01-28 Allergan Inc Production of prostamides
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
EP2488508A4 (en) * 2009-10-16 2013-04-24 Cayman Chemical Co Inc PROCESS FOR THE PREPARATION OF PROSTAGLANDINS OF THE F-SERIES
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
JP2020034682A (ja) 2018-08-29 2020-03-05 キオクシア株式会社 露光方法、露光制御装置および半導体装置の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
ZA765031B (en) * 1975-09-10 1977-10-26 Univ Chicago Fluorinated prostaglandins and related compounds and chemical process

Also Published As

Publication number Publication date
US4195183A (en) 1980-03-25
NL7705701A (nl) 1977-12-05
JPS6140662B2 (OSRAM) 1986-09-10
DE2721534A1 (de) 1977-12-15
NZ184187A (en) 1978-07-28
SE436026B (sv) 1984-11-05
FR2368473A1 (fr) 1978-05-19
JPS52148044A (en) 1977-12-08
AU2465677A (en) 1978-11-02
CS192484B2 (en) 1979-08-31
HU181424B (en) 1983-07-28
ATA383179A (de) 1981-12-15
SE7706310L (sv) 1977-12-02
GB1583263A (en) 1981-01-21
AT356302B (de) 1980-04-25
DK233377A (da) 1977-12-02
ATA333477A (de) 1979-09-15
AU509127B2 (en) 1980-04-24
CA1115700A (en) 1982-01-05
IL51877A (en) 1981-09-13
IL51877A0 (en) 1977-06-30
FR2368473B1 (OSRAM) 1981-09-11
BE855236A (fr) 1977-11-30
AT367747B (de) 1982-07-26
CH634831A5 (en) 1983-02-28

Similar Documents

Publication Publication Date Title
Corey et al. Stereospecific total synthesis of a" slow reacting substance" of anaphylaxis, leukotriene C-1
SU932985A3 (ru) Способ получени оптически активных или рацемических W-нор-ароматических-13,14-дегидропростагландинов или их солей
CA1079725A (en) Prostaglandin-acetylene analogues and process for their manufacture
SU900806A3 (ru) Способ получени производных простагландина
US4217360A (en) Novel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereof
Hart et al. Synthesis of C-aryl glycosides related to the chrysomycins
SE436873B (sv) 4,5-omettade prostansyraderivat
US4434101A (en) Inhibitors of SRS-synthesis
US4035415A (en) Omega-nor-cycloalkyl-13,14-dehydro-prostaglandins
Miyamoto et al. Synthetic studies on vitamin D analogues VI. A new synthesis of 25-hydroxycholesterol from lithocholic acid
GB2030144A (en) Keto-bicyclooctanes
US4703127A (en) Process for the preparation of prostanoids
US4338332A (en) Fluoro-prostaglandins
EP0585104B1 (en) A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor
US3736335A (en) Prostaglandins and methods of making same
US4089896A (en) 8,12-Diisoprostanoic acid derivatives
Harashima et al. Sodium bis (2-methoxyethoxy)(1, 1, 1, 3, 3, 3-hexafluoro-2-propoxy) aluminum hydride, a new stereoselective reducing agent in a carbacyclin synthesis
US4041064A (en) 16-Methyl prost-5-en-13-ynoic acid derivatives
US4414407A (en) Fluoro-prostaglandins and process for their preparation
US4220759A (en) 13,14-Dehydro-11-deoxy-prostaglandins and process for their preparation
JPS6033826B2 (ja) フルオロプロスタグランジン及びその製造法
SU1211251A1 (ru) Производные эндо-3-гидрокси-анти-2-(4-фенокси-3-гидрокси-1 @ -бутенил)-бицикло- @ 3,2,0 @ -гептан-6-она в качестве полупродукта дл синтеза 16-феноксизамещенных аналогов простагландина @ и (4-фенокси-3-алкокси-1 @ -бутенил)-1-пентилкупраты лити в качестве исходного дл получени производных эндо-3-гидрокси-анти-2(4-фенокси-3-гидрокси-1 @ -бутенил)-бицикло- @ 3,2,0 @ -гептан-6-она
US4055564A (en) Novel prostaglandin intermediates and process for the production thereof
CA1253494A (en) 12,16 - DIFLUOROPROSTAGLANDIN F.SUB.2.alpha. COMPOUNDS
PL88998B1 (en) Composition and process[au4154572a]